Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Dec 23, 2019 5:42pm

104 Views

Post# 30485642

RE:RE:RE:RE:10M Options Exercised in 2019

lscfa wrote: Suck it Don, you quack investor.

jun 26/15 - The Company also announces that it has granted incentive stock options under its stock option plan to directors, officers and employees of the company for the purchase of 4,200,000 common shares of the Company at a price of $0.16 per share. 3,600,000 of the options are for a ten year period, 600,000 are for a two year period.

Those are already accounted for, you moron.

It is the millions of options that we have no idea who got them, but were exercised this year, and if they are selling the resulting shares now or not.

You think you did some impressive DD there, but all you did was make yourself look stupid.

Bullboard Posts

Half of Canadians considering housing outside of large urban centres